Noriyuki Isohata Selected Research

FAP regimen

7/2008

Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriyuki Isohata Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 07/2006
8	Esophageal Neoplasms (Esophageal Cancer) 11/2011 - 09/2007
4	Rectal Neoplasms (Rectal Cancer) 08/2022 - 11/2008
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2019
3	Lymphatic Metastasis 01/2022 - 01/2010
3	Polyps 01/2022 - 12/2015
3	Neoplasm Metastasis (Metastasis) 12/2019 - 05/2008
3	Stomach Neoplasms (Stomach Cancer) 10/2011 - 07/2006
2	Hemorrhage 01/2022 - 11/2008
2	Esophageal and Gastric Varices (Esophageal Varices) 11/2008 - 09/2007
1	Proctitis 08/2022
1	Infections 05/2021
1	Spasm (Spasms) 06/2017
1	Atrophy 01/2017
1	Ascites 01/2017
1	Pathologic Constriction (Stenosis) 11/2011
1	Dyspnea (Shortness of Breath) 11/2011
1	Esophageal Stenosis (Esophageal Stricture) 11/2011
1	Coma (Comas) 09/2010
1	Dehydration (Water Stress) 09/2010
1	Hyponatremia 09/2010
1	Inappropriate ADH Syndrome (SIADH) 09/2010
1	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2010
1	Diabetes Mellitus 11/2009
1	Lymphocele 11/2008
1	Cysts 11/2008
1	Lung Neoplasms (Lung Cancer) 05/2008
1	Cutaneous Fistula 11/2007
1	Osteomyelitis 11/2007
1	Fever (Fevers) 09/2007
1	Pain (Aches) 09/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2007
1	Carcinoma (Carcinomatosis) 01/2007
1	Adenocarcinoma 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2007

Drug/Important Bio-Agent (IBA)

2	Bevacizumab (Avastin)FDA Link 12/2019 - 01/2017
2	Serum AlbuminIBA 05/2011 - 11/2009
2	Fluorouracil (Carac)FDA LinkGeneric 09/2010 - 07/2008
1	AntigensIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 06/2017
1	peppermint oilIBA 06/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	regorafenibIBA 01/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	Calmodulin-Binding Proteins (Caldesmon)IBA 09/2011
1	Vasopressins (Vasopressin)IBA 09/2010
1	nedaplatinIBA 09/2010
1	SodiumIBA 09/2010
1	PicibanilIBA 11/2008
1	Dihydrotachysterol (AT 10)IBA 11/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2008
1	Cisplatin (Platino)FDA LinkGeneric 07/2008
1	Thyroid Nuclear Factor 1IBA 05/2008
1	Keratins (Keratin)IBA 05/2008
1	cyclopamineIBA 07/2006
1	Biomarkers (Surrogate Marker)IBA 07/2006
1	LigandsIBA 07/2006

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 05/2021 - 09/2010
5	Esophagectomy 09/2010 - 01/2007
4	Neoadjuvant Therapy 01/2019 - 07/2008
3	Therapeutics 01/2022 - 07/2008
2	Stents 01/2022 - 11/2011
2	Lasers (Laser) 01/2016 - 09/2009
2	Lymph Node Excision (Lymph Node Dissection) 11/2008 - 01/2007
1	Proton Therapy 08/2022
1	Adjuvant Chemotherapy 01/2022
1	Decompression 01/2022
1	Hepatectomy 12/2019
1	Radiofrequency Ablation 12/2019
1	Electrocoagulation (Electrocautery) 12/2015
1	Radiotherapy 11/2011
1	Gastrectomy 05/2011
1	Length of Stay 11/2009
1	Sclerotherapy 11/2008
1	FAP regimen 07/2008
1	Aftercare (After-Treatment) 09/2007